TY - JOUR AU - Mohler, J. L. AU - Kantoff, P. W. AU - Armstrong, A. J. AU - Bahnson, R. R. AU - Cohen, M. AU - D’Amico, A. V. PY - 2014 DA - 2014// TI - Prostate cancer, version 2.2014. JO - J Natl Compr Canc Netw VL - 12 ID - Mohler2014 ER - TY - JOUR AU - Stewart, S. B. AU - Boorjian, S. A. PY - 2014 DA - 2014// TI - Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspective JO - Urol Oncol VL - 33 UR - https://doi.org/10.1016/j.urolonc.2014.10.003 DO - 10.1016/j.urolonc.2014.10.003 ID - Stewart2014 ER - TY - JOUR AU - Soares, R. AU - Eden, C. G. PY - 2014 DA - 2014// TI - Surgical treatment of high risk prostate cancer JO - Minerva Urol Nefrol VL - 67 ID - Soares2014 ER - TY - JOUR AU - Sundi, D. AU - Wang, V. M. AU - Pierorazio, P. M. AU - Han, M. AU - Bivalacqua, T. J. AU - Ball, M. W. PY - 2014 DA - 2014// TI - Very-high-risk localized prostate cancer: definition and outcomes JO - Prostate Cancer Prostatic Dis VL - 17 UR - https://doi.org/10.1038/pcan.2013.46 DO - 10.1038/pcan.2013.46 ID - Sundi2014 ER - TY - JOUR AU - Sundi, D. AU - Wang, V. AU - Pierorazio, P. M. AU - Han, M. AU - Partin, A. W. AU - Tran, P. T. PY - 2014 DA - 2014// TI - Identification of men with the highest risk of early disease recurrence after radical prostatectomy JO - Prostate VL - 74 UR - https://doi.org/10.1002/pros.22780 DO - 10.1002/pros.22780 ID - Sundi2014 ER - TY - JOUR AU - Narang, A. K. AU - Gergis, C. AU - Robertson, S. P. AU - He, P. AU - Ram, A. N. AU - McNutt, T. R. PY - 2016 DA - 2016// TI - Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation JO - Int J Radiat Oncol Biol Phys VL - 94 UR - https://doi.org/10.1016/j.ijrobp.2015.10.056 DO - 10.1016/j.ijrobp.2015.10.056 ID - Narang2016 ER - TY - JOUR AU - Saad, A. AU - Goldstein, J. AU - Lawrence, Y. R. AU - Weiss, I. AU - Saad, R. AU - Spieler, B. PY - 2015 DA - 2015// TI - Transperineal implantation of gold fiducial markers (gold seeds) for prostate image-guided radiation therapy: a feasible technique associated with a low risk of complications JO - J Med Radiat Sci VL - 62 UR - https://doi.org/10.1002/jmrs.122 DO - 10.1002/jmrs.122 ID - Saad2015 ER - TY - STD TI - Goldstein J, Even-Sapir E, Ben-Haim S, Saad A, Spieler B, Davidson T, Berger R, Weiss I, Appel S, Lawrence YR, Symon Z. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure? Am J Clin Oncol. 2014. [Epub ahead of print] PubMed PMID: 25319322 ID - ref8 ER - TY - JOUR AU - Roach, M. AU - Hanks, G. AU - Thames, H. AU - Schellhammer, P. AU - Shipley, W. U. AU - Sokol, G. H. PY - 2006 DA - 2006// TI - Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference JO - Int J Radiat Oncol Biol Phys VL - 65 UR - https://doi.org/10.1016/j.ijrobp.2006.04.029 DO - 10.1016/j.ijrobp.2006.04.029 ID - Roach2006 ER - TY - STD TI - National Cancer Institute. Common Terminology Criteria for Adverse Events v4.0. NCI, NIH, DHHS. May 29, 2009. NIH publication # 09-7473. ID - ref10 ER - TY - JOUR AU - Zelefsky, M. J. AU - Pei, X. AU - Chou, J. F. AU - Schechter, M. AU - Kollmeier, M. AU - Cox, B. PY - 2011 DA - 2011// TI - Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes JO - Eur Urol VL - 60 UR - https://doi.org/10.1016/j.eururo.2011.08.029 DO - 10.1016/j.eururo.2011.08.029 ID - Zelefsky2011 ER - TY - JOUR AU - Pahlajani, N. AU - Ruth, K. J. AU - Buyyounouski, M. K. AU - Chen, D. Y. AU - Horwitz, E. M. AU - Hanks, G. E. PY - 2012 DA - 2012// TI - Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 82 UR - https://doi.org/10.1016/j.ijrobp.2011.04.005 DO - 10.1016/j.ijrobp.2011.04.005 ID - Pahlajani2012 ER - TY - JOUR AU - Lawton, C. A. AU - DeSilvio, M. AU - Roach, M. AU - Uhl, V. AU - Kirsch, R. AU - Seider, M. PY - 2007 DA - 2007// TI - An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94–13, with emphasis on unexpected hormone/radiation interactions JO - Int J Radiat Oncol Biol Phys VL - 69 UR - https://doi.org/10.1016/j.ijrobp.2007.04.003 DO - 10.1016/j.ijrobp.2007.04.003 ID - Lawton2007 ER - TY - JOUR AU - Bolla, M. AU - Tienhoven, G. AU - Warde, P. AU - Dubois, J. B. AU - Mirimanoff, R. O. AU - Storme, G. PY - 2010 DA - 2010// TI - External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70223-0 DO - 10.1016/S1470-2045(10)70223-0 ID - Bolla2010 ER - TY - JOUR AU - Kaidar-Person, O. AU - Roach, M. AU - Crehange, G. PY - 2013 DA - 2013// TI - Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward JO - Int J Radiat Oncol Biol Phys VL - 86 UR - https://doi.org/10.1016/j.ijrobp.2013.02.006 DO - 10.1016/j.ijrobp.2013.02.006 ID - Kaidar-Person2013 ER - TY - JOUR AU - Stenmark, M. H. AU - Blas, K. AU - Halverson, S. AU - Sandler, H. M. AU - Feng, F. Y. AU - Hamstra, D. A. PY - 2011 DA - 2011// TI - Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease JO - Int J Radiat Oncol Biol Phys VL - 81 UR - https://doi.org/10.1016/j.ijrobp.2011.04.037 DO - 10.1016/j.ijrobp.2011.04.037 ID - Stenmark2011 ER - TY - JOUR AU - Moltzahn, F. AU - Karnes, J. AU - Gontero, P. AU - Kneitz, B. AU - Tombal, B. AU - Bader, P. PY - 2015 DA - 2015// TI - Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients JO - Prostate Cancer Prostatic Dis VL - 18 UR - https://doi.org/10.1038/pcan.2014.41 DO - 10.1038/pcan.2014.41 ID - Moltzahn2015 ER - TY - JOUR AU - Abdollah, F. AU - Sood, A. AU - Sammon, J. D. AU - Hsu, L. AU - Beyer, B. AU - Moschini, M. PY - 2015 DA - 2015// TI - Long-term Cancer Control Outcomes in Patients with Clinically High-risk Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Results from a Multi-institutional Study of 1100 Patients JO - Eur Urol VL - 68 UR - https://doi.org/10.1016/j.eururo.2015.06.020 DO - 10.1016/j.eururo.2015.06.020 ID - Abdollah2015 ER - TY - JOUR AU - Spratt, D. E. AU - Pei, X. AU - Yamada, J. AU - Kollmeier, M. A. AU - Cox, B. AU - Zelefsky, M. J. PY - 2013 DA - 2013// TI - Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 85 UR - https://doi.org/10.1016/j.ijrobp.2012.05.023 DO - 10.1016/j.ijrobp.2012.05.023 ID - Spratt2013 ER - TY - JOUR AU - Cozzarini, C. AU - Fiorino, C. AU - Pozzo, L. F. AU - Alongi, F. AU - Berardi, G. AU - Bolognesi, A. PY - 2012 DA - 2012// TI - Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients JO - Int J Radiat Oncol Biol Phys VL - 82 UR - https://doi.org/10.1016/j.ijrobp.2010.09.027 DO - 10.1016/j.ijrobp.2010.09.027 ID - Cozzarini2012 ER - TY - JOUR AU - Perna, L. AU - Alongi, F. AU - Fiorino, C. AU - Broggi, S. AU - Cattaneo Giovanni, M. AU - Cozzarini, C. PY - 2010 DA - 2010// TI - Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy JO - Radiother Oncol VL - 97 UR - https://doi.org/10.1016/j.radonc.2010.02.025 DO - 10.1016/j.radonc.2010.02.025 ID - Perna2010 ER - TY - JOUR AU - Pollack, A. AU - Zagars, G. K. AU - Starkschall, G. AU - Antolak, J. A. AU - Lee, J. J. AU - Huang, E. PY - 2002 DA - 2002// TI - Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial JO - Int J Radiat Oncol Biol Phys VL - 53 UR - https://doi.org/10.1016/S0360-3016(02)02829-8 DO - 10.1016/S0360-3016(02)02829-8 ID - Pollack2002 ER - TY - JOUR AU - Denham, J. W. AU - Steigler, A. AU - Joseph, D. AU - Lamb, D. S. AU - Spry, N. A. AU - Duchesne, G. PY - 2015 DA - 2015// TI - Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial JO - Radiother Oncol VL - 115 UR - https://doi.org/10.1016/j.radonc.2015.05.016 DO - 10.1016/j.radonc.2015.05.016 ID - Denham2015 ER - TY - STD TI - Lawrence YR, Samueli B, Levitin R, Pail O, Spieler B, Pfeffer R, Goldstein J, Den RB, Symon Z. Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based Study. Am J Clin Oncol. 2015. [Epub ahead of print] PubMed PMID: 26125304. ID - ref24 ER - TY - JOUR AU - Alexander, A. PY - 2011 DA - 2011// TI - Extreme-risk Prostate Adenocarcinoma Presenting with Prostate-specific Antigen (PSA) >40 ng/ml: Prognostic Significance of the Preradiation PSA Nadir JO - Int J Radiat Oncol Biol Phys VL - 81 UR - https://doi.org/10.1016/j.ijrobp.2010.11.068 DO - 10.1016/j.ijrobp.2010.11.068 ID - Alexander2011 ER - TY - JOUR AU - Rodrigues, G. AU - Bae, K. AU - Roach, M. AU - Lawton, C. AU - Donnelly, B. AU - Grignon, D. PY - 2011 DA - 2011// TI - Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials JO - Int J Radiat Oncol Biol Phys VL - 80 UR - https://doi.org/10.1016/j.ijrobp.2010.02.034 DO - 10.1016/j.ijrobp.2010.02.034 ID - Rodrigues2011 ER - TY - JOUR AU - Gontero, P. AU - Spahn, M. AU - Tombal, B. AU - Bader, P. AU - Hsu, C. Y. AU - Marchioro, G. PY - 2011 DA - 2011// TI - Is there a prostate-specific antigen upper limit for radical prostatectomy? JO - BJU Int VL - 108 UR - https://doi.org/10.1111/j.1464-410X.2011.10076.x DO - 10.1111/j.1464-410X.2011.10076.x ID - Gontero2011 ER - TY - JOUR AU - Jalloh, M. AU - Leapman, M. S. AU - Cowan, J. E. AU - Shinohara, K. AU - Greene, K. L. AU - Roach, M. PY - 2015 DA - 2015// TI - Patterns of Local Failure following Radiation Therapy for Prostate Cancer JO - J Urol VL - 194 UR - https://doi.org/10.1016/j.juro.2015.04.111 DO - 10.1016/j.juro.2015.04.111 ID - Jalloh2015 ER - TY - JOUR AU - Zumsteg, Z. S. AU - Spratt, D. E. AU - Romesser, P. B. AU - Pei, X. AU - Zhang, Z. AU - Kollmeier, M. PY - 2015 DA - 2015// TI - Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era for Prostate Patients Undergoing External Beam Radiotherapy JO - J Urol VL - 194 UR - https://doi.org/10.1016/j.juro.2015.06.100 DO - 10.1016/j.juro.2015.06.100 ID - Zumsteg2015 ER - TY - JOUR AU - Koontz, B. F. AU - Quaranta, B. P. AU - Pura, J. A. AU - Lee, W. R. AU - Vujaskovic, Z. AU - Gerber, L. PY - 2013 DA - 2013// TI - Phase 1 trial of neoadjuvant radiation therapy before prostatectomy for high-risk prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 87 UR - https://doi.org/10.1016/j.ijrobp.2013.05.014 DO - 10.1016/j.ijrobp.2013.05.014 ID - Koontz2013 ER - TY - JOUR AU - Oderda, M. AU - Joniau, S. AU - Spahn, M. AU - Gontero, P. PY - 2012 DA - 2012// TI - Debulking surgery in the setting of very high-risk prostate cancer scenarios JO - BJU Int VL - 110 UR - https://doi.org/10.1111/j.1464-410X.2012.10942.x DO - 10.1111/j.1464-410X.2012.10942.x ID - Oderda2012 ER - TY - JOUR AU - Mohler, J. L. AU - Kantoff, P. W. AU - Armstrong, A. J. AU - Bahnson, R. R. AU - Cohen, M. AU - D’Amico, A. V. PY - 2013 DA - 2013// TI - Prostate cancer, version 1.2014. JO - J Natl Compr Canc Netw VL - 11 ID - Mohler2013 ER - TY - JOUR AU - Nguyen, T. AU - Boldt, R. G. AU - Rodrigues, G. PY - 2015 DA - 2015// TI - Prognostic Factors for Prostate Cancer Endpoints Following Biochemical Failure: A Review of the Literature JO - Cureus VL - 7 ID - Nguyen2015 ER -